Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jul 27, 2023; 15(7): 1363-1374
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1363
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1363
Table 2 The postoperative complications of the ampullary carcinoma patients in the perioperative blood transfusion group and no perioperative blood transfusion group
Characteristic | No PBT | PBT | P value | ||
n = 113 | 100% | n = 144 | 100% | ||
Postoperative complications | 0.699 | ||||
No | 71 | 62.8% | 86 | 59.7% | |
Yes | 42 | 37.2% | 58 | 40.3% | |
Specific complications | |||||
PPH | 10 | 8.8% | 13 | 9.0% | 0.960 |
POPF | 16 | 14.2% | 22 | 15.3% | 0.802 |
DGE | 11 | 9.7% | 13 | 9.0% | 0.847 |
Intra-abdominal infection | 15 | 13.3% | 14 | 9.7% | 0.372 |
- Citation: Fei H, Zhang XJ, Sun CY, Li Z, Li ZF, Guo CG, Zhao DB. Impact of perioperative blood transfusion on oncological outcomes in ampullary carcinoma patients underwent pancreaticoduodenectomy. World J Gastrointest Surg 2023; 15(7): 1363-1374
- URL: https://www.wjgnet.com/1948-9366/full/v15/i7/1363.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i7.1363